- Previous Close
168.73 - Open
168.69 - Bid 169.25 x 800
- Ask 169.53 x 800
- Day's Range
167.74 - 169.85 - 52 Week Range
122.29 - 178.03 - Volume
51,789 - Avg. Volume
277,904 - Market Cap (intraday)
11.27B - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
34.01 - EPS (TTM)
4.98 - Earnings Date Feb 6, 2025 - Feb 10, 2025
- Forward Dividend & Yield 1.80 (1.07%)
- Ex-Dividend Date Oct 24, 2024
- 1y Target Est
188.00
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
www.aptar.com13,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ATR
View More
Performance Overview: ATR
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATR
View MoreValuation Measures
Market Cap
11.23B
Enterprise Value
12.03B
Trailing P/E
33.88
Forward P/E
30.58
PEG Ratio (5yr expected)
2.62
Price/Sales (ttm)
3.18
Price/Book (mrq)
4.42
Enterprise Value/Revenue
3.37
Enterprise Value/EBITDA
16.31
Financial Highlights
Profitability and Income Statement
Profit Margin
9.40%
Return on Assets (ttm)
7.01%
Return on Equity (ttm)
14.08%
Revenue (ttm)
3.57B
Net Income Avi to Common (ttm)
335.95M
Diluted EPS (ttm)
4.98
Balance Sheet and Cash Flow
Total Cash (mrq)
327.91M
Total Debt/Equity (mrq)
45.31%
Levered Free Cash Flow (ttm)
318.36M
Research Analysis: ATR
View MoreCompany Insights: ATR
ATR does not have Company Insights
Research Reports: ATR
View MoreLowering target price to $175.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $175.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetRaising target price to $184.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $184.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetRaising target price to $179.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $179.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetRaising target price to $177.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $177.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target